 | Up a level |
Karlsen, Tom H; Rutter, Harry; Carrieri, Patrizia; Zelber-Sagi, Shira; Engebretsen, Eivind; Hutchinson, Sharon; Voigt, Kristin; Guha, Neil; Berzigotti, Annalisa; Schomerus, Georg; Gines, Pere; Buti, Maria; Burra, Patrizia; Manns, Michael P; Krag, Aleksander; Kleinert, Sabine (2024). The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality. The lancet, 403(10436), pp. 1522-1524. Elsevier 10.1016/S0140-6736(24)00204-6
Andrade, Raúl J; Aithal, Guruprasad P; de Boer, Ynto S; Liberal, Rodrigo; Gerbes, Alexander; Regev, Arie; Beretta-Piccoli, Benedetta Terziroli; Schramm, Christoph; Kleiner, David E; De Martin, Eleonora; Kullak-Ublick, Gerd A; Stirnimann, Guido; Devarbhavi, Harshad; Vierling, John M; Manns, Michael P; Sebode, Marcial; Londoño, Maria Carlota; Avigan, Mark; Robles-Diaz, Mercedes; García-Cortes, Miren; ... (2023). Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. Journal of hepatology, 79(3), pp. 853-866. Elsevier 10.1016/j.jhep.2023.04.033
Behrendt, Patrick; Perin, Paula; Menzel, Nicolas; Banda, Dominic; Pfänder, Stephanie; Alves, Marco; Thiel, Volker Earl; Meulemann, Phillip; Colpitts, Che C; Schang, Luis M; Vondran, Florian W R; Anggakusuma, A; Manns, Michael P; Steinmann, Eike; Pietschmann, Thomas (2017). Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. Antiviral research, 147, pp. 19-28. Elsevier 10.1016/j.antiviral.2017.09.006
Maan, Raoel; Zaim, Remziye; van der Meer, Adriaan J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry LA; Veldt, Bart J; de Knegt, Robert J; Uyl-de Groot, Carin A (2016). Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(11), pp. 1851-1859. Wiley-Blackwell Publishing Asia 10.1111/jgh.13373
van der Meer, Adriaan J; Maan, Raoel; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Zeuzem, Stefan; Peter Hofmann, W; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2015). Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(6), pp. 1168-1176. Wiley-Blackwell Publishing Asia 10.1111/jgh.13252
Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2015). Risk of infections during interferon-based treatment in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 30(6), pp. 1057-1064. Wiley-Blackwell Publishing Asia 10.1111/jgh.12929
van der Meer, Adriaan J; Hansen, Bettina E; Fattovich, Giovanna; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Ieluzzi, Donatella; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Veldt, Bart J; Janssen, Harry L A (2015). Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters. Gut, 64(2), pp. 322-331. BMJ Publishing Group 10.1136/gutjnl-2013-305357
Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Zangneh, Hooman F; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2014). Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of hepatology, 61(3), pp. 482-491. Elsevier 10.1016/j.jhep.2014.04.021
van der Meer, Adriaan J; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Heathcote, E Jenny; Manns, Michael P; Kuske, Lorenz; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2012). Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA - the journal of the American Medical Association, 308(24), pp. 2584-93. Chicago, Ill.: American Medical Association 10.1001/jama.2012.144878
Veldt, Bart J; Chen, Wendong; Heathcote, E Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, W Peter; de Knegt, Robert J; Zeuzem, Stefan; Manns, Michael P; Hansen, Bettina E; Schalm, Solko W; Janssen, Harry L A (2008). Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology, 47(6), pp. 1856-62. Hoboken, N.J.: Wiley Interscience 10.1002/hep.22251
Veldt, Bart J; Heathcote, E Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, W Peter; Zeuzem, Stefan; Manns, Michael P; Hansen, Bettina E; Schalm, Solko W; Janssen, Harry L A (2007). Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Annals of internal medicine, 147(10), pp. 677-84. Philadelphia, Pa.: American College of Physicians
